Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions

Healthy Volunteers

Interventions

DRUG

5 Methoxy N,N Dimethyltryptamine

GH001 administered via inhalation

Trial Locations (1)

RECRUITING

GH Research Clinical Trial Site, London

All Listed Sponsors

lead

GH Research Ireland Limited

INDUSTRY

NCT06511947 - Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects | Biotech Hunter | Biotech Hunter